Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $50.31 in the prior trading day, American Healthcare REIT Inc (NYSE: AHR) closed at $49.97, down -0.68%. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 1.9 million shares were traded. AHR stock price reached its highest trading level at $51.015 during the session, while it also had its lowest trading level at $49.875.
Ratios:
Our goal is to gain a better understanding of AHR by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.63. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In the most recent recommendation for this company, UBS on September 19, 2025, initiated with a Buy rating and assigned the stock a target price of $51.
On July 18, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $41.
On June 30, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $42.Scotiabank initiated its Sector Outperform rating on June 30, 2025, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’25 when Foster Mark E. sold 1,500 shares for $49.35 per share. The transaction valued at 74,030 led to the insider holds 57,600 shares of the business.
Mark Foster bought 1,500 shares of AHR for $74,030 on Nov 11 ’25. On Nov 10 ’25, another insider, Hanson Jeffrey T, who serves as the Director of the company, sold 20,010 shares for $49.68 each. As a result, the insider received 994,105 and left with 21,798 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHR now has a Market Capitalization of 9307639808 and an Enterprise Value of 10432110592. As of this moment, American’s Price-to-Earnings (P/E) ratio for their current fiscal year is 354.90, and their Forward P/E ratio for the next fiscal year is 69.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.26 while its Price-to-Book (P/B) ratio in mrq is 3.19. Its current Enterprise Value per Revenue stands at 4.756 whereas that against EBITDA is 27.807.
Stock Price History:
The Beta on a monthly basis for AHR is 0.97, which has changed by 0.7621716 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, AHR has reached a high of $50.91, while it has fallen to a 52-week low of $26.40. The 50-Day Moving Average of the stock is 10.09%, while the 200-Day Moving Average is calculated to be 32.22%.
Shares Statistics:
The stock has traded on average 1.69M shares per day over the past 3-months and 2352890 shares per day over the last 10 days, according to various share statistics. A total of 185.51M shares are outstanding, with a floating share count of 183.89M. Insiders hold about 0.88% of the company’s shares, while institutions hold 83.93% stake in the company. Shares short for AHR as of 1763078400 were 3140482 with a Short Ratio of 1.86, compared to 1760486400 on 7222033. Therefore, it implies a Short% of Shares Outstanding of 3140482 and a Short% of Float of 1.78.
Earnings Estimates
. The current rating of American Healthcare REIT Inc (AHR) reflects the combined expertise of 3.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.14, with high estimates of $0.15 and low estimates of $0.14.
Analysts are recommending an EPS of between $0.52 and $0.5 for the fiscal current year, implying an average EPS of $0.51. EPS for the following year is $0.71, with 3.0 analysts recommending between $0.79 and $0.58.
Revenue Estimates
6 analysts predict $615.39M in revenue for. The current quarter. It ranges from a high estimate of $659.3M to a low estimate of $579.37M. As of. The current estimate, American Healthcare REIT Inc’s year-ago sales were $542.74MFor the next quarter, 6 analysts are estimating revenue of $627.87M. There is a high estimate of $713M for the next quarter, whereas the lowest estimate is $587.1M.
A total of 6 analysts have provided revenue estimates for AHR’s current fiscal year. The highest revenue estimate was $2.32B, while the lowest revenue estimate was $2.23B, resulting in an average revenue estimate of $2.27B. In the same quarter a year ago, actual revenue was $2.07BBased on 6 analysts’ estimates, the company’s revenue will be $2.53B in the next fiscal year. The high estimate is $2.76B and the low estimate is $2.4B.
